ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
98,043.10
0.29%
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs Yen
156.455
0.00%
Brent Oil
72.72
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Quoin Pharmaceuticals Ltd (QNRX) 銘柄情報

Quoin Pharmaceuticals Ltd

Quoin Pharmaceuticals Ltd (QNRX)

NASDAQ
0.569
-0.0778
(-12.03%)
終了 12月21日 6:00AM
15分遅延
0.544
-0.025
(-4.39%)
取引時間後: 9:53AM
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.544
買値
0.54
売値
0.80
出来高
2,219,418
0.425 日の範囲 0.625
0.00 52 週間の範囲 0.00
時価総額
2.747M
前日終値
0.6468
始値
0.425
時刻
350
@
0.544
(formt)
最終取引時間
財務取引量
US$ 1,270,965
VWAP
0.572657
平均取引量 (3 か月)
-
発行済株式数
5,049,720
配当利回り
-
PER
0.00
1 株当たり利益 (EPS)
-
歳入
-
純利益
-8.69M

Quoin Pharmaceuticals Ltd について

Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Neth... Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. 詳細を表示

セクター
Medicinal Chems,botanicl Pds
業界
Cmp Programming,data Process
ウェブサイト
www.cellect.co
本社
Kfar Saba, Center, Isr
設立
2007
Quoin Pharmaceuticals Ltd is listed in the Medicinal Chems,botanicl Pds sector of the ナスダック市場 with ticker QNRX. The last closing price for Quoin Pharmaceuticals was US$0.65. Over the last year, Quoin Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Quoin Pharmaceuticals currently has 5,049,720 shares in issue. The market capitalisation of Quoin Pharmaceuticals is US$3.27 million.

QNRX 最新ニュース

その他のニュース

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

ASHBURN, Va., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and...

21時間前
GlobeNewswire Inc.

Form 8-K - Current report

2024年12月19日
Edgar (US Regulatory)

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

Groundbreaking ‘Whole Body’ Study will be conducted by Dr. Amy Paller at Northwestern University Up to eight subjects will have QRX003 applied twice daily to greater than 80% of their body surface...

2024年12月19日
GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

2024年12月19日
Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after...

2024年12月18日
GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933

2024年12月12日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月11日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月11日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月11日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月11日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

QNRX - Frequently Asked Questions (FAQ)

What is the current Quoin Pharmaceuticals share price?
The current share price of Quoin Pharmaceuticals is US$ 0.544
How many Quoin Pharmaceuticals shares are in issue?
Quoin Pharmaceuticals has 5,049,720 shares in issue
What is the market cap of Quoin Pharmaceuticals?
The market capitalisation of Quoin Pharmaceuticals is USD 3.27M
What is the 1 year trading range for Quoin Pharmaceuticals share price?
Quoin Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the reporting currency for Quoin Pharmaceuticals?
Quoin Pharmaceuticals reports financial results in USD
What is the latest annual profit for Quoin Pharmaceuticals?
The latest annual profit of Quoin Pharmaceuticals is USD -8.69M
What is the registered address of Quoin Pharmaceuticals?
The registered address for Quoin Pharmaceuticals is 23 HATA’AS STREET, KFAR SABA, CENTER, 44425
What is the Quoin Pharmaceuticals website address?
The website address for Quoin Pharmaceuticals is www.cellect.co
Which industry sector does Quoin Pharmaceuticals operate in?
Quoin Pharmaceuticals operates in the CMP PROGRAMMING,DATA PROCESS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

QNRX Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
QNRX
Quoin Pharmaceuticals
LSE
XMID
Xindonesiasw 1c
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有